OXFORD, United Kingdom & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Oxford Immunotec Inc, announces the release of new Centers for Disease Control and Prevention (CDC) guidelines for using interferon gamma release assays (IGRA) to detect Mycobacterium tuberculosis infection. For the first time, the CDC make specific recommendations for which an IGRA is preferred over use of the 100+ year-old tuberculin skin test (TST), including persons who have received the BCG vaccination, and for persons unlikely to return for the required reading of results needed to complete the test.
